Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ALW-II-41-27 |
Trade Name | |
Synonyms | |
Drug Descriptions |
ALW-II-41-27 is a small molecule that inhibits EPHA2 and RET, leading to decreased tumor cell proliferation and viability (PMID: 24713656, PMID: 26046350, PMID: 32848131). |
DrugClasses | RET Inhibitor 53 |
CAS Registry Number | 1186206-79-0 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ALW-II-41-27 | ALW-II-41-27 | 4 | 0 |
ALW-II-41-27 + Cetuximab | ALW-II-41-27 Cetuximab | 0 | 0 |
ALW-II-41-27 + Paclitaxel | ALW-II-41-27 Paclitaxel | 0 | 0 |